Atlas Trials

Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease

Clinical trial NCT01894594 · TERMINATED

Trial details

NCT number
NCT01894594
Sponsor
University Hospitals Cleveland Medical Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Sickle Cell AnemiaChronic Kidney DiseaseMetabolic Acidosis
Start date
2013-06-01
Primary completion
2019-03-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.